BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24726647)

  • 21. Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Ferrandino F; Bernardini G; Tsaouli G; Grazioli P; Campese AF; Noce C; Ciuffetta A; Vacca A; Besharat ZM; Bellavia D; Screpanti I; Felli MP
    Oncogene; 2018 Dec; 37(49):6285-6298. PubMed ID: 30038265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
    Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
    PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
    Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
    Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
    Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
    Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
    Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
    Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
    Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
    Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
    Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway.
    Liu Y; Fang B; Feng X; Jiang Y; Zeng Y; Jiang J
    Tissue Cell; 2022 Feb; 74():101674. PubMed ID: 34814054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
    Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
    Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen.
    Ma S; Shi Y; Pang Y; Dong F; Cheng H; Hao S; Xu J; Zhu X; Yuan W; Cheng T; Zheng G
    J Hematol Oncol; 2014 Nov; 7():71. PubMed ID: 25366136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
    Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG
    Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.
    Varnum-Finney B; Xu L; Brashem-Stein C; Nourigat C; Flowers D; Bakkour S; Pear WS; Bernstein ID
    Nat Med; 2000 Nov; 6(11):1278-81. PubMed ID: 11062542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
    Ito M; Kobayashi K; Nakahata T
    Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models.
    Campagnari A; Belver L
    Methods Mol Biol; 2024; 2773():9-24. PubMed ID: 38236532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ADAR1 Knockout Inhibits Notch1-induced T-ALL in Mice].
    Gao HE; Peng LY; Yang X; Zhang YC; Hu TY; Xu J; Yuan WP; Cheng T; Gao YD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):643-8. PubMed ID: 27342484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.
    Zhu W; Zhu Y; Xu H; Wang T; Wang J; Meng M; Liu Y; Yan H; Yang Q; Liu P
    Biochem Biophys Res Commun; 2020 Feb; 522(3):684-689. PubMed ID: 31785807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic Kras initiates leukemia in hematopoietic stem cells.
    Sabnis AJ; Cheung LS; Dail M; Kang HC; Santaguida M; Hermiston ML; Passegué E; Shannon K; Braun BS
    PLoS Biol; 2009 Mar; 7(3):e59. PubMed ID: 19296721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.